Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

PROTHENA CORP PUBLIC LTD CO

PRTA · Nasdaq · CIK 0001559053 · Healthcare · Biotechnology

INSIDER SIGNAL

63.2 / 100

1 buyers · 17 purchase transaction lines · $10.9M gross purchase

WHY THIS SIGNAL?

Buyer breadthLow
Purchase sizeStrong
RoleModerate
RecencyStrong
ConvictionStrong
Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+7.0 / 35
Purchase size+23.0 / 25
Role+14.0 / 20
Recency+9.4 / 10
Conviction+9.9 / 10

What is holding the score back?

  • ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
  • ⚠ Role scores low · most senior buyer: TenPercentOwner (CEO, chair and 10% owners score lowest)
  • ✓ Recent activity · latest purchase 2026-10-14

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
SCULLY WILLIAM PTenPercentOwner
●●●●○●●○○○●●●●●●●●●●
Swanson Chad J.Chief Development Officer
○○○
Kingston Anne EvansChief Strategy Officer
○▼
Isaacs Michael JohnGeneral Counsel & Company Sec.
○▼
Zago Wagner M.Chief Scientific Officer
○○
Walker Karin LChief Accounting Officer
○○
● Purchase▼ Sale○ Other

Showing the six most active owners; 3 additional owner(s) remain in Form 4 evidence.

Purchase breadth & concentration

QUALIFYING BUYERS1
PURCHASE CONCENTRATION100%Largest buyer: SCULLY WILLIAM P · $10.9M
CLUSTER BUYING · 15D1 insiderPeak activity: 2026-05-22–2026-06-04

Roles in the peak window: TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

63.2 / 100

Latest recorded score

↓ -0.4 ptsversus the previous recorded snapshot
  1. 62.9
  2. 62.8
  3. 62.6
  4. 63.6
  5. 63.2

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

17Purchases
2Sales
19Other Form 4 lines
25SEC filings · 365 days
BUYING17 qualifying P line(s) · 180 days
SELLING2 sale line(s) · context only
OTHER19 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot detected in parsed evidence

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
-1.3%
3M
-3.7%
6M
-23.4%
12M
-21.7%

Volatility & liquidity

Volatility
64.3%
Beta
—
Avg daily value
USD 4.1M

Valuation

Market cap
—
P/E
—

Fundamentals

Profit margin
—
ROE
-87.0%
Industry
Biotechnology

Market data

Price data up to: 2026-10-18 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: ROE · Fiscal year ended: 2025-12-31 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
8,010,864
Previous report
8,544,664
Avg daily volume
580,885
Days to cover
13.8

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-14SCULLY WILLIAM PPurchase (P)Ordinary Shares, par value $0.01 per share10,000USD 8.46USD 84,569SEC filing ↗
2026-10-13SCULLY WILLIAM PPurchase (P)Ordinary Shares, par value $0.01 per share100,000USD 8.35USD 835,480SEC filing ↗
2026-10-08SCULLY WILLIAM PPurchase (P)Ordinary Shares, par value $0.01 per share90,000USD 8.57USD 770,904SEC filing ↗
2026-10-07SCULLY WILLIAM PPurchase (P)Ordinary Shares, par value $0.01 per share125,000USD 8.40USD 1,050,150SEC filing ↗
2026-10-02SCULLY WILLIAM PPurchase (P)Ordinary Shares, par value $0.01 per share100,000USD 8.57USD 857,240SEC filing ↗
2026-09-29SCULLY WILLIAM PPurchase (P)Ordinary Shares, par value $0.01 per share162,000USD 8.68USD 1,406,160SEC filing ↗
2026-09-28SCULLY WILLIAM PPurchase (P)Ordinary Shares, par value $0.01 per share103,500USD 8.60USD 890,100SEC filing ↗
2026-09-18SCULLY WILLIAM PPurchase (P)Ordinary Shares, par value $0.01 per share100,000USD 8.43USD 843,000SEC filing ↗
2026-09-02SCULLY WILLIAM PPurchase (P)Ordinary Shares, par value $0.01 per share27,000USD 9.47USD 255,690SEC filing ↗
2026-08-20SCULLY WILLIAM PPurchase (P)Ordinary Shares, par value $0.01 per share50,000USD 8.79USD 439,500SEC filing ↗
2026-08-07SCULLY WILLIAM PPurchase (P)Ordinary Shares, par value $0.01 per share37,500USD 8.62USD 323,250SEC filing ↗
2026-06-16SCULLY WILLIAM PPurchase (P)Ordinary Shares, par value $0.01 per share20,000USD 7.90USD 158,000SEC filing ↗
2026-06-11SCULLY WILLIAM PPurchase (P)Ordinary Shares, par value $0.01 per share125,000USD 8.17USD 1,021,250SEC filing ↗
2026-06-04SCULLY WILLIAM PPurchase (P)Ordinary Shares, par value $0.01 per share50,000USD 9.31USD 465,500SEC filing ↗
2026-06-02SCULLY WILLIAM PPurchase (P)Ordinary Shares, par value $0.01 per share50,000USD 9.43USD 471,500SEC filing ↗

Form 4 evidence

38 transaction lines in the latest 365-day window; 472 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-14SCULLY WILLIAM PPurchase (P)Ordinary Shares, par value $0.01 per share10,000USD 8.46USD 84,569SEC filing ↗
2026-10-13SCULLY WILLIAM PPurchase (P)Ordinary Shares, par value $0.01 per share100,000USD 8.35USD 835,480SEC filing ↗
2026-10-08SCULLY WILLIAM PPurchase (P)Ordinary Shares, par value $0.01 per share90,000USD 8.57USD 770,904SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-14SCULLY WILLIAM PPurchase (P)Ordinary Shares, par value $0.01 per share10,000USD 8.46USD 84,569SEC filing ↗
2026-10-13SCULLY WILLIAM PPurchase (P)Ordinary Shares, par value $0.01 per share100,000USD 8.35USD 835,480SEC filing ↗
2026-10-08SCULLY WILLIAM PPurchase (P)Ordinary Shares, par value $0.01 per share90,000USD 8.57USD 770,904SEC filing ↗
2026-10-07SCULLY WILLIAM PPurchase (P)Ordinary Shares, par value $0.01 per share125,000USD 8.40USD 1,050,150SEC filing ↗
2026-10-02SCULLY WILLIAM PPurchase (P)Ordinary Shares, par value $0.01 per share100,000USD 8.57USD 857,240SEC filing ↗
2026-09-29SCULLY WILLIAM PPurchase (P)Ordinary Shares, par value $0.01 per share162,000USD 8.68USD 1,406,160SEC filing ↗
2026-09-28SCULLY WILLIAM PPurchase (P)Ordinary Shares, par value $0.01 per share103,500USD 8.60USD 890,100SEC filing ↗
2026-09-18SCULLY WILLIAM PPurchase (P)Ordinary Shares, par value $0.01 per share100,000USD 8.43USD 843,000SEC filing ↗
2026-09-02SCULLY WILLIAM PPurchase (P)Ordinary Shares, par value $0.01 per share27,000USD 9.47USD 255,690SEC filing ↗
2026-08-20SCULLY WILLIAM PPurchase (P)Ordinary Shares, par value $0.01 per share50,000USD 8.79USD 439,500SEC filing ↗
2026-08-18SCULLY WILLIAM PGift (G)Ordinary Shares, par value $0.01 per share627,553USD 0.00USD 0SEC filing ↗
2026-08-17SCULLY WILLIAM PGift (G)Ordinary Shares, par value $0.01 per share336,000USD 0.00USD 0SEC filing ↗
2026-08-10SCULLY WILLIAM PGift (G)Ordinary Shares, par value $0.01 per share251,553USD 0.00USD 0SEC filing ↗
2026-08-07SCULLY WILLIAM PPurchase (P)Ordinary Shares, par value $0.01 per share37,500USD 8.62USD 323,250SEC filing ↗
2026-07-29Kingston Anne EvansSale (S)Ordinary Shares, par value $0.01 per share7,662USD 8.47USD 64,897SEC filing ↗
2026-07-29Isaacs Michael JohnSale (S)Ordinary Shares, par value $0.01 per share8,386USD 8.47USD 71,029SEC filing ↗
2026-07-28Zago Wagner M.Option exercise / conversion (M)Ordinary Shares, par value $0.01 per share51,000USD —USD —SEC filing ↗
2026-07-28Zago Wagner M.D (D)Ordinary Shares, par value $0.01 per share51,000USD 8.56USD 436,560SEC filing ↗
2026-07-28Walker Karin LOption exercise / conversion (M)Ordinary Shares, par value $0.01 per share15,000USD —USD —SEC filing ↗
2026-07-28Walker Karin LD (D)Ordinary Shares, par value $0.01 per share15,000USD 8.56USD 128,400SEC filing ↗
2026-07-28Swanson Chad J.Option exercise / conversion (M)Ordinary Shares, par value $0.01 per share51,000USD —USD —SEC filing ↗
2026-07-28Swanson Chad J.Tax withholding (F)Ordinary Shares, par value $0.01 per share3,467USD 8.56USD 29,678SEC filing ↗
2026-07-28Swanson Chad J.D (D)Ordinary Shares, par value $0.01 per share40,800USD 8.56USD 349,248SEC filing ↗
2026-07-28Smith Brandon S.Option exercise / conversion (M)Ordinary Shares, par value $0.01 per share78,000USD —USD —SEC filing ↗
2026-07-28Smith Brandon S.D (D)Ordinary Shares, par value $0.01 per share78,000USD 8.56USD 667,680SEC filing ↗
2026-07-28Nguyen TranOption exercise / conversion (M)Ordinary Shares, par value $0.01 per share57,000USD —USD —SEC filing ↗
2026-07-28Nguyen TranD (D)Ordinary Shares, par value $0.01 per share57,000USD 8.56USD 487,920SEC filing ↗
2026-07-28Kinney Gene G.Option exercise / conversion (M)Ordinary Shares, par value $0.01 per share84,000USD —USD —SEC filing ↗
2026-07-28Kinney Gene G.D (D)Ordinary Shares, par value $0.01 per share84,000USD 8.56USD 719,040SEC filing ↗
2026-07-28Kingston Anne EvansTax withholding (F)Ordinary Shares, par value $0.01 per share3,498USD 8.56USD 29,943SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerPRTA
CIK0001559053
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history472 transaction lines from 2020-04-08 to 2026-10-14
34 P purchase lines · 282 S sale lines · 156 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.